Profil
Andrew H.
Chang worked as a Director of Investor Relations at Astellas Gene Therapies, Inc. and later as the Head of Investor Relations and Corporate Communication at Applied Molecular Transport, Inc. from 2020 to 2023.
Anciens postes connus de Andrew H. Chang
Sociétés | Poste | Fin |
---|---|---|
APPLIED MOLECULAR TRANSPORT INC. | Investor Relations Contact | 27/12/2023 |
AUDENTES THERAPEUTICS, INC. | Investor Relations Contact | 01/01/2020 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
APPLIED MOLECULAR TRANSPORT INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Astellas Gene Therapies, Inc.
Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. | Health Technology |